Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
11.75
-1.16 (-8.99%)
Nov 21, 2024, 4:00 PM EST - Market closed
Gyre Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,008 | 1,967 | - |
| Enterprise Value | 1,120 | 1,946 | - |
| Last Close Price | 12.91 | 25.69 | - |
| PS Ratio | 10.05 | 17.34 | - |
| PB Ratio | 17.53 | 25.07 | - |
| P/FCF Ratio | - | 113.23 | - |
| P/OCF Ratio | 422.70 | 75.99 | - |
| EV/Sales Ratio | 10.66 | 17.15 | - |
| EV/EBITDA Ratio | 94.90 | 95.72 | - |
| EV/EBIT Ratio | 107.93 | 101.27 | - |
| EV/FCF Ratio | - | 111.99 | - |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | 0.14 | 0.02 | 0.06 |
| Debt / FCF Ratio | - | 0.02 | 0.11 |
| Asset Turnover | - | 1.13 | - |
| Inventory Turnover | - | 0.89 | - |
| Quick Ratio | 3.11 | 2.49 | 3.33 |
| Current Ratio | 3.72 | 2.85 | 4.06 |
| Return on Equity (ROE) | -85.32% | -113.45% | - |
| Return on Assets (ROA) | - | 11.93% | - |
| Return on Capital (ROIC) | 6.54% | 15.83% | - |
| Earnings Yield | -8.48% | -4.72% | - |
| FCF Yield | -0.21% | 0.88% | - |
| Buyback Yield / Dilution | -28.56% | 13.02% | - |
| Total Shareholder Return | -28.56% | 13.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.